HCP Live December 8, 2023
While specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.
Alzheimer disease (AD) is defined by the presence of amyloid plaques and tangles in the brain leading to progressive memory loss and an inability to carry out daily function. In 2020, as many as 5.8 million Americans were living with AD, with this number projected to nearly triple by 2060.1 As society continues to age, AD poses as a serious challenge for the medical community and neurologists specifically.
What was once seen as a disease that began with old age, advances in research have shown that AD is a continuous process that...
Today's Sponsors
Today's Sponsor